Goldman Sachs Reports Amedisys, Inc. Holding Falls Below 5% Threshold
AMEDISYS, INC.
Filing Summary
Goldman Sachs Reports Amedisys Holding Falls Below 5%
Company: AMEDISYS, INC. (Ticker: N/A) Form: SCHEDULE 13G/A | Filed: 2025-11-14 Significance: Low
Reporting Institution: THE GOLDMAN SACHS GROUP, INC. Relationship: Institutional Investor (>5% Owner)
Transaction: • Type: Position Update / Cessation of >5% beneficial ownership • Security: Common Stock • Shares Owned After: 190 • Ownership %: 0.0%
Key Insight: Goldman Sachs filed to report its beneficial ownership in Amedisys, Inc. has fallen to a nominal 190 shares, representing 0.0% of the class. This is a standard filing indicating the institution is no longer a greater-than-5% owner.
Market Context: This amendment to a Schedule 13G is a routine disclosure for a large financial institution adjusting its portfolio and does not typically signal a strategic shift regarding the subject company. The position was held passively.
Comprehensive Analysis
SEC Filing Analysis: AMEDISYS, INC.
Executive Summary
- Trading Significance: Low
- Key Takeaway: Goldman Sachs has filed a Schedule 13G/A to report it is no longer a beneficial owner of more than 5% of Amedisys, Inc.'s common stock, with its remaining holding reduced to a nominal 190 shares (0.0%).
- Market Impact: Neutral. This is a routine portfolio adjustment by a large financial institution and is not considered market-moving.
Company Information
| Field | Value |
|---|---|
| Company | AMEDISYS, INC. |
| Ticker Symbol | Not specified in filing |
| CIK | 0000896262 |
| Industry | Home Health Care Services |
Reporting Institution Information
| Field | Value |
|---|---|
| Name | THE GOLDMAN SACHS GROUP, INC. |
| CIK | 0000886982 |
| Relationship | Institutional Investor |
Transaction Details
| Field | Value |
|---|---|
| Form Type | SCHEDULE 13G/A |
| Event Date | 2025-09-30 |
| Security Type | Common Stock, par value $0.001 per share |
| Shares Owned After | 190 |
| Ownership Percentage | 0.0% |
| Ownership Type | Indirect |
Financial Impact Assessment
Transaction Materiality
Market data for the subject company (AMEDISYS, INC.) was not provided, so a detailed materiality analysis (% of market cap, % of shares outstanding) cannot be performed.
- Materiality Assessment: Low. The filing indicates a cessation of a >5% position, reducing holdings to a negligible amount. For a large institution like Goldman Sachs, exiting such a position is considered part of the ordinary course of business.
Impact Evaluation
- Ownership Concentration: The filing confirms that a major institutional holder has effectively exited its significant position, slightly decreasing ownership concentration among large funds.
- Transaction Significance: The significance is low as it represents a passive investment position being closed out, which is a common activity for a broker-dealer and asset manager like Goldman Sachs. The filing certifies the shares were not held for the purpose of influencing control of the issuer.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Schedule 13G filings denote passive investment stakes. An amendment showing a reduction below the 5% reporting threshold by a non-activist institution is a standard disclosure and is not expected to have a direct impact on the stock price.
Volume & Sentiment
- Expected Volume Impact: Minimal. The trades that led to this change in ownership have already occurred. The filing itself is unlikely to trigger significant new trading volume.
- Sentiment Indicator: Neutral. This action does not provide a clear bullish or bearish signal; it is a portfolio management adjustment.
Additional Context
Transaction Notes
- This is an amendment ('/A') to a previous Schedule 13G, filed because the reporting person's beneficial ownership has fallen below 5% of the outstanding common stock. The event triggering the filing occurred on September 30, 2025.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.